Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wesley Mark Todd"'
Publikováno v:
Current Therapeutic Research. 55:1003-1115
A randomized, controlled, double-blind, double-dummy, multicenter study compared the efficacy and safety of cefpodoxime proxetil with that of cefaclor in the outpatient treatment of community-acquired pneumonia. A total of 325 patients received 7 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e06addd4502650ced6377d3d81f3c8
https://doi.org/10.1016/s0011-393x(05)80270-x
https://doi.org/10.1016/s0011-393x(05)80270-x
Autor:
Wesley Mark Todd
Publikováno v:
International Journal of Antimicrobial Agents. 4:37-62
Cefpodoxime proxetil, a relatively new broad-spectrum third-generaation cephalosporin, has very good in vitro activity against Enterobacteriaceae, Hemophilus spp. and Moraxella spp., including beta-lactamase producers and many strains resistant to ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88107a4227f63a4602c986d36d057f48
https://doi.org/10.1016/0924-8579(94)90062-0
https://doi.org/10.1016/0924-8579(94)90062-0
Publikováno v:
The Pediatric Infectious Disease Journal. 12:275-279
This multicenter, randomized, parallel treatment, observer-blinded study was designed to evaluate the safety and efficacy of cefpodoxime proxetil (5 mg/kg twice daily for 10 days) compared with penicillin V (13.4 mg/kg three times daily for 10 days)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4de380ea62574a118d61afdabeabd26
https://doi.org/10.1097/00006454-199304000-00003
https://doi.org/10.1097/00006454-199304000-00003
Publikováno v:
The Journal of Pediatrics. 121:459-465
In a multicenter, randomized, investigator-blinded trial, patients were randomly selected to receive either cefpodoxime proxetil or amoxicillin-clavulanate potassium orally for the treatment of acute suppurative otitis media. Patients were seen befor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc984aa3a8c7d34afabf564c20144b1d
https://doi.org/10.1016/s0022-3476(05)81805-0
https://doi.org/10.1016/s0022-3476(05)81805-0
Autor:
Leon G. Smith, Maureen A. Mcconnell-Martin, Dennis L. Stevens, Wesley Mark Todd, Sue E. Duvall, Barry Hafkin, Jon B. Bruss
Publikováno v:
Antimicrobial agents and chemotherapy. 44(12)
This randomized, double-blind, multicenter trial compared the efficacy and safety of linezolid, an oxazolidinone, with those of oxacillin-dicloxacillin in patients with complicated skin and soft tissue infections. A total of 826 hospitalized adult pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be185e5cfc4440557a002519de0a8aa2
https://pubmed.ncbi.nlm.nih.gov/11083648
https://pubmed.ncbi.nlm.nih.gov/11083648
Autor:
Mary C. Birmingham, Susan M. Flavin, Barry Hafkin, Rayner R Craig, Jerome J. Schentag, Jennifer D. Root, Donald H. Batts, Gabrial S. Zimmer, Wesley Mark Todd
Publikováno v:
Critical Care Medicine. 27:A33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a72589b8272d0e1e34f53a7b36fce57
https://doi.org/10.1097/00003246-199912001-00042
https://doi.org/10.1097/00003246-199912001-00042
Autor:
Wesley Mark Todd
Publikováno v:
Drug Information Journal. 23:669-672
Phase I studies constitute the foundation upon which the entire drug development program must be built. A properly conducted Phase I program should define the dose range, potential side effects, duration of action, and route of excretion for the drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7addcf8d14dba02ebe4d3604dc63a517
https://doi.org/10.1177/009286158902300421
https://doi.org/10.1177/009286158902300421